Wuhan Mental Health Centre
Wuhan, Hubei, 430022, China
NCT Number: NCT06170996
This study aims to investigate the effectiveness of an Internet-based behavioural parent training intervention on children's ADHD symptoms and children's and parents' mental health status.
Looking for future studies?
Notify Me6 year–12 year
All sexes
Interventional
Not applicable
Wuhan, Hubei, 430022, China
The study design was a 2-parallel-group experimental longitudinal study. Firstly, the children received a diagnostic interview by an experienced child and adolescent psychiatrist at Wuhan Mental Health Centre for confirmation of inclusion and exclusion criteria. Parents who were eligible for the inclusion criteria and interested in the internet-based behavioural Parent Training (I-BPT) program were recruited. After the assessments of ADHD symptoms and psychiatric comorbidity, participants were randomly assigned in a 1:1 ratio to either the routine clinical care (RCC) group or I-BPT+RCC group using computer-generated randomization numbers. Participants in the I-BPT+RCC group were offered 2 months (8 weeks) of internet-assisted parent training in addition to routine outpatient treatment. The RCC group initially received only routine outpatient treatment, yet, after post-follow-up assessment, they were provided with the same I-BPT intervention for ethical considerations. Both groups were followed up after intervention by electronic questionnaire.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Internet-based behavioural parent training in a group format, 8 sessions over 2 months, delivered by a systematically trained and supervised therapist.
Time frame: From baseline to 2 months
This questionnaire consists of two symptom domains: inattention (9 items) and hyperactivity/impulsivity (9 items). Each item of SNAP-IV assigned a score from 0 (never or rarely) to 3 (very often), with a higher score indicating more severe ADHD symptoms.
Time frame: From baseline to 2 months
This scale consists of 50 items, each with a score ranging from 0 to 3, a higher average score indicates a greater impairment.
Time frame: From baseline to 2 months
This scale encompasses 41 items, each item ranges from 0 to 2, with a higher score indicating more severe anxiety symptoms.
Time frame: From baseline to 2 months
The CDI-S consists of 10 items, each scored with 0, 1, or 2 points. Depression is rated on a scale of 0 to 15; higher scores indicate more serious symptoms of depression.
Time frame: From baseline to 2 months
The GAD is a 7-item self-reported questionnaire, with a total score ranging from 0 to 21, and a higher score indicating increased anxiety.
Time frame: From baseline to 2 months
The PHQ-9 scale comprises nine items, assigning scores from 0 (not at all) to 3 (nearly every day). The total score of the PHQ-9 questionnaire ranged from 0 to 27, with a higher score indicating more severe depressive symptoms.
Time frame: From baseline to 2 months
This scale consists of 15 items, with a total score from 15 to 75. The higher score indicates more higher stress level.
Time frame: posttest: 2 months to pretest
The CSQ-I consists of 8 items, with a total score of 0 to 32. The higher scores correspond to greater satisfaction of participants.
Wuhan Mental Health Centre
Other
Internet-Based Behavioural Parent Training Intervention for Children With Attention-Deficit/Hyperactivity Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07521449
ADHD, Attention Deficit Disorder with Hyperactivity
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07376863
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD)
Adana, Turkey (Türkiye)
View Trial DetailsNCT07333339
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD)
Bursa, Turkey (Türkiye)
View Trial DetailsNCT07231354
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD)
Thessaloniki, Greece
View Trial Details